Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy

Association between Child？Turcotte？Pugh (CTP) score and pretreatment plasma hepatocyte growth factor (HGF) in liver cancer patients undergoing hypofractionated radiation therapy with protons. a, b Plasma HGF concentration is significantly higher in patients with worsening in CTP score by at least 1 point after radiation therapy within 3 months a and within 6 months b. Data shown as median values and range